Lobbying client
BURLINGTON CAPITOL GROUP
Investment
Filings
12
Filed by
1
Reported in-house
—
Reported by firms
—
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2015 to 2017
Filings
12 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
4th Quarter - Termination (No Activity) 4th Quarter 2017
|
LOU LINEHAN | — reported |
|
4th Quarter - Report (No Activity)replaced 4th Quarter 2017
|
LOU LINEHAN | — reported |
|
3rd Quarter - Report (No Activity) 3rd Quarter 2017
|
LOU LINEHAN | — reported |
|
2nd Quarter - Report (No Activity) 2nd Quarter 2017
|
LOU LINEHAN | — reported |
|
1st Quarter - Amendment (No Activity) 1st Quarter 2017
|
LOU LINEHAN | — reported |
|
4th Quarter - Report (No Activity) 4th Quarter 2016
|
LOU LINEHAN | — reported |
|
3rd Quarter - Amendment (No Activity) 3rd Quarter 2016
|
LOU LINEHAN | — reported |
|
3rd Quarter - Report (No Activity)replaced 3rd Quarter 2016
|
LOU LINEHAN | — reported |
|
2nd Quarter - Amendment (No Activity) 2nd Quarter 2016
|
LOU LINEHAN | — reported |
|
4th Quarter - Report (No Activity) 4th Quarter 2015
|
LOU LINEHAN | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| LOU LINEHAN | 9 | — |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Medical/Disease Research/Clinical Labs | MED | 1 |
| Foreign Relations | FOR | 1 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.